What’s next for rare myelomas?
Effective antibody therapy and updates from the POLLUX and CASTER trials at IMW
How effective are current drug treatments for patients with myeloma kidney disease?
Exciting new treatments in myeloma
HDACs in multiple myeloma: potential benefits in maintenance phase